Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis (Q47803059)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

0 references

author name string

Tae-Bin Won

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Song-Hua Quan

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Dong-Young Kim

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Chae-Seo Rhee

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Chul Hee Lee

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

publication date

1 April 2009

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

102

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

314-322

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Actions of cholera toxin and the prevention and treatment of cholera

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG DNA: a pathogenic factor in systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma☆☆☆★

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal CpG DNA therapy during allergen exposure in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Necessity of oligonucleotide aggregation for toll-like receptor 9 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960337-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60337-7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19441603

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47803059&oldid=2171520480"